Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Clinical Recovery With Meropenem-Azithromycin Combination Therapy in Extensively Drug-Resistant Typhoid Feve

NCT07445282 is registered in ClinicalTrials.gov with Sheikh Zayed Medical College as lead sponsor.

NCT NCT07445282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07445282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Clinical Recovery With Meropenem-Azithromycin Combination Therapy in Extensively Drug-Resistant Typhoid Feve
Lead sponsor
Sheikh Zayed Medical College
Phase
Phase 4
Overall status
Completed
Start date
May 14, 2025
Completion date
November 14, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extensively drug-resistant typhoid fever, salmonella typhi infection, typhoid fever